当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析

博瑞医药

(688166)

  

流通市值:217.05亿  总市值:217.05亿
流通股本:4.23亿   总股本:4.23亿

博瑞医药(688166)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.02亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益258616.69万元,未分配利润94282.56万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产538379.46万元,负债279762.76万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入537,438,662.14248,959,843.431,282,551,614.5976,825,695.67
营业总成本549,542,369.7266,560,026.021,102,598,723.72798,339,394.77
其他经营收益
营业利润-4,822,123.74-11,896,358.17160,289,049.93168,350,913.52
利润总额-5,021,225.35-11,863,878.89157,200,608.4168,076,343.14
净利润1,657,076.47-4,656,771.18141,263,284.54146,757,526.84
每股收益
其他综合收益-2,579,713.14-70,221.14-37,833,359.39-35,070,709.12
综合收益总额-922,636.67-4,726,992.32103,429,925.15111,686,817.72
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,543,927,667.971,571,596,585.711,640,277,766.141,382,517,329.28
非流动资产:
非流动资产合计3,839,866,910.553,713,676,711.13,516,240,676.753,496,015,482.52
资产总计5,383,794,578.525,285,273,296.815,156,518,442.894,878,532,811.8
流动负债:
流动负债合计1,157,002,452.45938,194,263.591,052,385,357.52885,484,629.78
非流动负债:
非流动负债合计1,640,625,190.991,731,062,179.251,678,103,094.391,650,708,519.23
负债合计2,797,627,643.442,669,256,442.842,730,488,451.912,536,193,149.01
所有者权益(或股东权益):
归属于母公司股东权益合计2,474,316,681.222,501,618,781.222,383,301,688.472,352,381,122.67
股东权益合计2,586,166,935.082,616,016,853.972,426,029,990.982,342,339,662.79
负债和股东权益合计5,383,794,578.525,285,273,296.815,156,518,442.894,878,532,811.8
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计562,391,959.6317,907,169.841,117,870,607.02904,023,277.15
经营活动现金流出小计448,779,178.59210,914,177.33872,311,289.92784,433,575.12
经营活动产生的现金流量净额113,612,781.01106,992,992.51245,559,317.1119,589,702.03
投资活动产生的现金流量:
投资活动现金流入小计46,722,764.426,160155,841,559.4298,281,859.09
投资活动现金流出小计434,025,408.32227,303,774.99595,983,083.56523,154,996.71
投资活动产生的现金流量净额-387,302,643.9-227,297,614.99-440,141,524.14-424,873,137.62
筹资活动产生的现金流量:
筹资活动现金流入小计748,699,300518,151,900926,077,074.15595,962,819.75
筹资活动现金流出小计504,588,160.26348,760,914.55950,551,978.01769,729,870.72
筹资活动产生的现金流量净额244,111,139.74169,390,985.45-24,474,903.86-173,767,050.97
汇率变动对现金及现金等价物的影响6,309,982.473,123,026.272,118,247.621,333,672.34
现金及现金等价物净增加额-23,268,740.6852,209,389.24-216,938,863.28-477,716,814.22
期末现金及现金等价物余额730,833,190.27806,311,320.19754,101,930.95493,323,980.01
补充资料:
现金及现金等价物的净增加额-23,268,740.68--216,938,863.28-
最新报告期:2025-09-15
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东吴证券朱国广0.620.721.032025-09-15
开源证券阮帅,余汝意0.150.310.492025-09-03
浙商证券郭双喜0.440.490.622025-08-03
东吴证券朱国广0.620.721.032025-08-02
东吴证券朱国广0.620.721.032025-07-21
TOP↑